<PubmedArticle>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24162898</PMID>
<DateCompleted>
<Year>2014</Year>
<Month>05</Month>
<Day>27</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1941-3297</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>7</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2014</Year>
<Month>Jan</Month>
</PubDate>
</JournalIssue>
<Title>Circulation. Heart failure</Title>
<ISOAbbreviation>Circ Heart Fail</ISOAbbreviation>
</Journal>
<ArticleTitle>Impact of atrial fibrillation on exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study.</ArticleTitle>
<Pagination>
<MedlinePgn>123-30</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1161/CIRCHEARTFAILURE.113.000568</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Atrial fibrillation (AF) is common among patients with heart failure and preserved ejection fraction (HFpEF), but its clinical profile and impact on exercise capacity remain unclear. RELAX (Phosphodiesterase-5 Inhibition to Improve Clinical Status and Exercise Capacity in HFpEF) was a multicenter randomized trial testing the impact of sildenafil on peak VO2 in stable outpatients with chronic HFpEF. We sought to compare clinical features and exercise capacity among patients with HFpEF who were in sinus rhythm (SR) or AF.</AbstractText>
<AbstractText Label="METHODS AND RESULTS" NlmCategory="RESULTS">RELAX enrolled 216 patients with HFpEF, of whom 79 (37%) were in AF, 124 (57%) in SR, and 13 in other rhythms. Participants underwent baseline cardiopulmonary exercise testing, echocardiogram, biomarker assessment, and rhythm status assessment before randomization. Patients with AF were older than those in SR but had similar symptom severity, comorbidities, and renal function. Î²-blocker use and chronotropic indices were also similar. Despite comparable left ventricular size and mass, AF was associated with worse systolic (lower EF, stroke volume, and cardiac index) and diastolic (shorter deceleration time and larger left atria) function compared with SR. Pulmonary artery systolic pressure was higher in AF. Patients with AF had higher N-terminal pro-B-type natriuretic peptide, aldosterone, endothelin-1, troponin I, and C-telopeptide for type I collagen levels, suggesting more severe neurohumoral activation, myocyte necrosis, and fibrosis. Peak VO2 was lower in AF, even after adjustment for age, sex, and chronotropic response, and VE/VCO2 was higher.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">AF identifies an HFpEF cohort with more advanced disease and significantly reduced exercise capacity. These data suggest that evaluation of the impact of different rate or rhythm control strategies on exercise tolerance in patients with HFpEF and AF is warranted.</AbstractText>
<AbstractText Label="CLINICAL TRIAL REGISTRATION" NlmCategory="BACKGROUND">URL: http://www.clinicaltrials.gov. Unique identifier: NCT00763867.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Zakeri</LastName>
<ForeName>Rosita</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Division of Cardiology, Mayo Clinic, Rochester, MN.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Borlaug</LastName>
<ForeName>Barry A</ForeName>
<Initials>BA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>McNulty</LastName>
<ForeName>Steven E</ForeName>
<Initials>SE</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Mohammed</LastName>
<ForeName>Selma F</ForeName>
<Initials>SF</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Lewis</LastName>
<ForeName>Gregory D</ForeName>
<Initials>GD</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Semigran</LastName>
<ForeName>Marc J</ForeName>
<Initials>MJ</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Deswal</LastName>
<ForeName>Anita</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>LeWinter</LastName>
<ForeName>Martin</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Hernandez</LastName>
<ForeName>Adrian F</ForeName>
<Initials>AF</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Braunwald</LastName>
<ForeName>Eugene</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Redfield</LastName>
<ForeName>Margaret M</ForeName>
<Initials>MM</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<DataBankList CompleteYN="Y">
<DataBank>
<DataBankName>ClinicalTrials.gov</DataBankName>
<AccessionNumberList>
<AccessionNumber>NCT00763867</AccessionNumber>
</AccessionNumberList>
</DataBank>
</DataBankList>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>U01HL084875</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01 HL084890</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01 HL084891</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>UL1TR000135</GrantID>
<Acronym>TR</Acronym>
<Agency>NCATS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U54 MD007588</GrantID>
<Acronym>MD</Acronym>
<Agency>NIMHD NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>UL1TR000454</GrantID>
<Acronym>TR</Acronym>
<Agency>NCATS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U10HL110262</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01HL084890</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01 HL084931</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01HL084889</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01HL084861</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01 HL084875</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01 HL084861</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U10 HL084904</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>T32 HL007111</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01HL084931</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 HL105418</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01HL084907</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01HL084877</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01 HL084907</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>UL1 TR000135</GrantID>
<Acronym>TR</Acronym>
<Agency>NCATS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U10 HL110262</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01 HL084904</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>UL1 TR000454</GrantID>
<Acronym>TR</Acronym>
<Agency>NCATS NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01HL084904</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01 HL084899</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01HL084891</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01 HL084877</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01HL084899</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>U01 HL084889</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016448">Multicenter Study</PublicationType>
<PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2013</Year>
<Month>10</Month>
<Day>25</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Circ Heart Fail</MedlineTA>
<NlmUniqueID>101479941</NlmUniqueID>
<ISSNLinking>1941-3289</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D058986">Phosphodiesterase 5 Inhibitors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D010879">Piperazines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011687">Purines</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D013450">Sulfones</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>BW9B0ZE037</RegistryNumber>
<NameOfSubstance UI="D000068677">Sildenafil Citrate</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000367">Age Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001281">Atrial Fibrillation</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001794">Blood Pressure</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015331">Cohort Studies</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015897">Comorbidity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017079">Exercise Tolerance</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006333">Heart Failure</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000453">epidemiology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000503">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006339">Heart Rate</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010101">Oxygen Consumption</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D058986">Phosphodiesterase 5 Inhibitors</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010879">Piperazines</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D011687">Purines</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000068677">Sildenafil Citrate</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013318">Stroke Volume</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000502">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013450">Sulfones</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">atrial fibrillation</Keyword>
<Keyword MajorTopicYN="N">exercise</Keyword>
<Keyword MajorTopicYN="N">heart failure</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2013</Year>
<Month>10</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2013</Year>
<Month>10</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2014</Year>
<Month>5</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">24162898</ArticleId>
<ArticleId IdType="pii">CIRCHEARTFAILURE.113.000568</ArticleId>
<ArticleId IdType="doi">10.1161/CIRCHEARTFAILURE.113.000568</ArticleId>
<ArticleId IdType="pmc">PMC3972021</ArticleId>
<ArticleId IdType="mid">NIHMS552655</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Am J Physiol Heart Circ Physiol. 2006 Aug;291(2):H921-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16461374</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Sci (Lond). 1991 Jun;80(6):633-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1647928</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 2013 Mar 27;309(12):1268-77</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23478662</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Chest. 1992 Oct;102(4):1017-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1395736</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Circulation. 2003 Jun 17;107(23):2920-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12771006</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Circulation. 2007 May 8;115(18):2410-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17452607</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neth Heart J. 2013 Jul;21(7-8):354-63</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23700039</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Circulation. 1995 Jan 15;91(2):580-615</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7805272</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Am Coll Cardiol. 1997 Oct;30(4):1039-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9316536</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Cardiol. 2003 Mar 20;91(6A):2D-8D</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12670636</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Heart. 2009 Jun;95(11):924-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19282313</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Card Fail. 2012 Sep;18(9):702-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22939039</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2004 Dec 2;351(23):2373-83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15575053</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Am Coll Cardiol. 2013 May 7;61(18):1894-903</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23500267</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Circulation. 1968 Apr;37(4):543-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">5649079</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Am Coll Cardiol. 2006 May 16;47(10):1997-2004</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16697316</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am Rev Respir Dis. 1984 Feb;129(2 Pt 2):S49-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">6421218</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Am Coll Cardiol. 2013 Oct 15;62(16):e147-239</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23747642</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur Heart J. 2008 Oct;29(19):2367-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18682448</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Card Fail. 2010 Feb;16(2):128-34</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20142024</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Am Coll Cardiol. 1997 Jun;29(7):1585-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9180123</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2008 Jun 19;358(25):2667-77</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18565859</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Circulation. 2006 Nov 14;114(20):2138-47</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17088459</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Am Soc Echocardiogr. 2005 Dec;18(12):1440-63</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16376782</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur Heart J. 1985 Sep;6(9):773-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">4076212</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur Heart J. 2002 May;23(10):806-14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12009721</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Circulation. 2000 May 2;101(17):2118-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10790356</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JACC Heart Fail. 2013 Feb;1(1):21-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24621795</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Acta Physiol Scand Suppl. 1960;49(169):1-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">13794892</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Circ Heart Fail. 2009 Mar;2(2):113-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19808326</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Cardiol. 2011 Nov 1;108(9):1283-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21855829</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Heart Fail. 2013 Nov;15(11):1311-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23759284</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Appl Physiol (1985). 1986 Jun;60(6):2020-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3087938</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Card Fail. 2007 Oct;13(8):649-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17923357</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Circ Heart Fail. 2012 Sep 1;5(5):653-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22991405</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Heart Fail. 2008 Jun;10(6):566-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18456551</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Heart. 1997 Dec;78(6):564-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9470871</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Cardiol. 1996 Jun 1;77(14):1250-2</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8651109</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Intern Med. 2011 Oct;22(5):466-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21925054</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Physiol Heart Circ Physiol. 2004 Dec;287(6):H2899-905</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15284065</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am Heart J. 2005 Jun;149(6):1106-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15976795</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur Heart J. 1996 Jun;17(6):926-34</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8781833</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Circulation. 2001 Oct 16;104(16):1911-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11602493</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Heart Fail. 2011 Oct;13(10):1111-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21642293</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Heart Fail. 2011 Dec;13(12):1296-304</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21979991</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am Heart J. 2004 Nov;148(5):910-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15523326</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2010 Apr 15;362(15):1363-73</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20231232</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</PubmedArticle>